Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.49 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 6/20 | 0.46 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | DAGLA | Q9Y4D2 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16199754 | 0.81 | ZDHHC7 (0.51) | ZDHHC7PLA2G2APLA2G2CBIRC2ABCB1 | |
| SCHEMBL9731631 | 0.81 | ZDHHC7 (0.51) | ZDHHC7PLA2G2APLA2G2CBIRC2ABCB1 | |
| SCHEMBL16199773 | 0.81 | ZDHHC7 (0.51) | ZDHHC7PLA2G2APLA2G2CBIRC2ABCB1 | |
| SCHEMBL11685164 | 0.80 | ABCB1 (0.49) | ZDHHC7PLA2G2APLA2G2CBIRC2ABCB1 | |
| SCHEMBL10602631 | 0.76 | GPR84 (0.48) | PLA2G2APLA2G2CFAAH | |
| SCHEMBL19085541 | 0.74 | ZDHHC7 (0.53) | ZDHHC7PLA2G2APLA2G2CBIRC2ABCB1 | |
| SCHEMBL8232200 | 0.74 | ZDHHC7 (0.53) | ZDHHC7PLA2G2APLA2G2CBIRC2ABCB1 | |
| SCHEMBL28534551 | 0.72 | ZDHHC7 (0.56) | ZDHHC7BIRC2ABCB1CNR1FAAH | |
| SCHEMBL28951567 | 0.72 | ZDHHC7 (0.56) | ZDHHC7BIRC2ABCB1CNR1FAAH | |
| SCHEMBL560716 | 0.71 | ZDHHC7 (0.63) | ZDHHC7BIRC2ABCB1CNR1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190194242-A1 | PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF | UNIVERSITY OF COLORADO BOULDER | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194242-A1 | PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF | POLN, POLRMT, NUDT21 | ZDHHC7 4448/4885PLA2G2A 1065/4885PLA2G2C 345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.